Summary:
A Phase 1, Randomized, Double-blind, Placebo-controlled
Trial to Assess the Tolerability, Safety, and Pharmacokinetics
of Ascending Single Oral Tablet Doses of OPC-214870 in
Healthy Subjects and in Healthy Japanese Subjects and the
Effect of a High-Fat Meal
Qualified Participants Must:
• Be Males 18 to 45 years of age
•
Be Caucasian or Japanese
Qualified Participants May Receive:
Compensation for time and travel